e-learning
resources
Vienna 2012
Monday, 03.09.2012
Pharmacological and non-pharmacological management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Costs and effectiveness of a disease management program for chronic obstructive pulmonary disease
A. Porcu, S. Balestracci, M. Polselli, B. Marsiglia, FIMMG Progetto MITO, A. Macuzzi, P.C. Rossi, M. Moretti (Carrara, Italy)
Source:
Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Session:
Pharmacological and non-pharmacological management of COPD
Session type:
Poster Discussion
Number:
2905
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Porcu, S. Balestracci, M. Polselli, B. Marsiglia, FIMMG Progetto MITO, A. Macuzzi, P.C. Rossi, M. Moretti (Carrara, Italy). Costs and effectiveness of a disease management program for chronic obstructive pulmonary disease. Eur Respir J 2012; 40: Suppl. 56, 2905
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Efficacy of a smoking-cessation programme in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 166s
Year: 2001
Proactive integrated care improves quality of life in patients with COPD
Source: Eur Respir J 2009; 33: 1031-1038
Year: 2009
Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021
Selection of patients with chronic obstructive pulmonary disease for participation in self-management programs.
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020
Epidemiology and costs of chronic obstructive pulmonary disease - Supplementary material: Final Q and A Global Burden of COPD
Source: Eur Respir J 2006; 27: 188-207
Year: 2006
Epidemiology and costs of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 27: 188-207
Year: 2006
Costs of chronic obstructive pulmonary disease in Sweden
Source: Eur Respir J 2002; 20: Suppl. 38, 125s
Year: 2002
Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation
Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure
Year: 2003
Evaluation of health quality of patients with asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2011 - The eclectic world of respiratory nursing
Year: 2011
Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
Source: Guideline 1995
Year: 1995
Use of telehealth in the management of patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Tiotropium in the management of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 205-206
Year: 2002
Socioeconomic burden of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=463
Year: 2006
The economic burden of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010
Improvement of diagnosis and treatment of obstructive lung diseases with a one stop diagnostic consultancy
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006
Trends in healthcare utilization and costs prior to a chronic obstructive pulmonary disease (COPD) diagnosis
Source: Eur Respir J 2006; 28: Suppl. 50, 36s
Year: 2006
Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 243-244
Year: 2002
Telemedicine in chronic obstructive pulmonary disease
Source: Breathe 2016; 12: 350-356
Year: 2016
The usefulness of pedometry in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept